Carlos Doti, MD

Carlos Doti, MD

Articles by Carlos Doti, MD

Carlos Doti, MDBreast Cancer News | March 26, 2025
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
View More